|Articles|September 1, 2001
- Applied Clinical Trials-09-01-2001
Domenico Criscuolo
As well as being a committed European, Domenico Criscuolo is a powerful supporter of the Italian clinical research community.
Advertisement
Articles in this issue
almost 25 years ago
Connecting at the Connectathonalmost 25 years ago
Patient Demands vs. Product Developmentalmost 25 years ago
EU Proposes Authorization Changesalmost 25 years ago
FDA Warning Lettersalmost 25 years ago
The Clinical Audit in Pharmaceutical Developmentalmost 25 years ago
What a Form 483 Really Meansalmost 25 years ago
Effective Invvestigator Meetingsalmost 25 years ago
Randomized Controlled Trialsalmost 25 years ago
A New Challange for Central Laboratoriesalmost 25 years ago
Monitoring Where Others Take HolidaysAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
Bringing the Voice of Clinical Practice and Patients into Drug Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5